254 filings
Page 4 of 13
8-K
mtvbkagy
18 Nov 22
Entry into a Material Definitive Agreement
4:22pm
8-K
3nkpspclu 37
21 Oct 22
Regulation FD Disclosure
4:14pm
8-K
qn5a1sbz8
11 Oct 22
Regulation FD Disclosure
7:36am
8-K
rvy9rh1noqz3
19 Aug 22
Other Events
5:42pm
S-8
i8haxh5v66974443j6n0
15 Aug 22
Registration of securities for employees
8:32pm
8-K
so4et ykfboz
24 Jun 22
Submission of Matters to a Vote of Security Holders
5:01pm
DEFA14A
8fa0 lib6c
5 May 22
Additional proxy soliciting materials
8:31am
8-K
2dz5d16 sl038feig
5 May 22
Genprex Issues Shareholder Letter and Provides 2022 Corporate Update
8:30am
DEFA14A
12r482ba
28 Apr 22
Additional proxy soliciting materials
4:29pm
8-K
mqti9h
27 Apr 22
Regulation FD Disclosure
4:13pm
8-K
wxng4nxl9
31 Mar 22
Genprex Announces the Opening for Enrollment of its Phase 1/2 Acclaim-2 Clinical Trial
7:06am
8-K
fo6vmdr24pz4
2 Mar 22
Genprex Announces First Patient Dosed in Phase 1/2 Acclaim-1 Clinical Trial of
8:00am
8-K
td4dg6fou dausifp
8 Feb 22
Departure of Directors or Certain Officers
4:23pm
8-K
1um ju3z9ee50j7vpk
4 Jan 22
Other Events
8:08am